5-(5-((2-Hydroxycyclopentyl)methyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrazin-3-yl)-7-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one

ID: ALA4085864

Chembl Id: CHEMBL4085864

PubChem CID: 137644548

Max Phase: Preclinical

Molecular Formula: C18H23N7O2

Molecular Weight: 369.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(-c2cnn3c2CN(CC2CCCC2O)CC3)c2c(=O)[nH]cnn12

Standard InChI:  InChI=1S/C18H23N7O2/c1-11-22-16(17-18(27)19-10-21-25(11)17)13-7-20-24-6-5-23(9-14(13)24)8-12-3-2-4-15(12)26/h7,10,12,15,26H,2-6,8-9H2,1H3,(H,19,21,27)

Standard InChI Key:  OTGWXKUTFIPMEB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4085864

    ---

Associated Targets(Human)

PDE2A Tclin Phosphodiesterase 2A (1799 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

MDCKII-LE (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.43Molecular Weight (Monoisotopic): 369.1913AlogP: 0.57#Rotatable Bonds: 3
Polar Surface Area: 104.34Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.34CX Basic pKa: 7.18CX LogP: -1.05CX LogD: -1.26
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.70Np Likeness Score: -0.42

References

1. Obach RS, Walker GS, Sharma R, Jenkinson S, Tran TP, Stepan AF..  (2018)  Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 Inhibitors.,  61  (8): [PMID:29601185] [10.1021/acs.jmedchem.8b00116]
2. Obach RS, Walker GS, Sharma R, Jenkinson S, Tran TP, Stepan AF..  (2018)  Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 Inhibitors.,  61  (8): [PMID:29601185] [10.1021/acs.jmedchem.8b00116]

Source